Faber WR - Search Results

1

Use of ML dipstick as a tool to classify leprosy patients.

Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JA, Vieira LM, de Matos HJ, Faber WR, Klatser PR. Buhrer-Sekula S, et al. Among authors: faber wr. Int J Lepr Other Mycobact Dis. 2000 Dec;68(4):456-63. Int J Lepr Other Mycobact Dis. 2000. PMID: 11332289

2

Risk factors for developing leprosy--a population-based cohort study in Indonesia.

Bakker MI, Hatta M, Kwenang A, Van Mosseveld P, Faber WR, Klatser PR, Oskam L. Bakker MI, et al. Among authors: faber wr. Lepr Rev. 2006 Mar;77(1):48-61. Lepr Rev. 2006. PMID: 16715690

3

Use of NASBA RNA amplification for detection of Mycobacterium leprae in skin biopsies from untreated and treated leprosy patients.

van der Vliet GM, Cho SN, Kampirapap K, van Leeuwen J, Schukkink RA, van Gemen B, Das PK, Faber WR, Walsh GP, Klatser PR. van der Vliet GM, et al. Among authors: faber wr. Int J Lepr Other Mycobact Dis. 1996 Dec;64(4):396-403. Int J Lepr Other Mycobact Dis. 1996. PMID: 9030105

4

Dipstick assay to identify leprosy patients who have an increased risk of relapse.

Bührer-Sékula S, Cunha MG, Foss NT, Oskam L, Faber WR, Klatser PR. Bührer-Sékula S, et al. Among authors: faber wr. Trop Med Int Health. 2001 Apr;6(4):317-23. doi: 10.1046/j.1365-3156.2001.00704.x. Trop Med Int Health. 2001. PMID: 11348523 Free article.

5

Role of PGL-I antibody detection in the diagnosis of pure neural leprosy.

Jardim MR, Antunes SL, Simons B, Wildenbeest JG, Nery JA, Illarramendi X, Moraes MO, Martinez AN, Oskam L, Faber WR, Sarno EN, Sampaio EP, Bührer-Sékula S. Jardim MR, et al. Among authors: faber wr. Lepr Rev. 2005 Sep;76(3):232-40. Lepr Rev. 2005. PMID: 16248210

6

The relation between seroprevalence of antibodies against phenolic glycolipid-I among school children and leprosy endemicity in Brazil.

Bührer-Sékula S, van Beers S, Oskam L, Lecco R, Madeira ES, Dutra MA, Luis MC, Faber WR, Klatser PR. Bührer-Sékula S, et al. Among authors: faber wr. Rev Soc Bras Med Trop. 2008;41 Suppl 2:81-8. doi: 10.1590/s0037-86822008000700017. Rev Soc Bras Med Trop. 2008. PMID: 19618082 Free article.

7

Population survey to determine risk factors for Mycobacterium leprae transmission and infection.

Bakker MI, Hatta M, Kwenang A, Faber WR, van Beers SM, Klatser PR, Oskam L. Bakker MI, et al. Among authors: faber wr. Int J Epidemiol. 2004 Dec;33(6):1329-36. doi: 10.1093/ije/dyh266. Epub 2004 Jul 15. Int J Epidemiol. 2004. PMID: 15256520

8

Elimination of leprosy and its consequences for research.

Faber WR, Klatser PR. Faber WR, et al. Adv Exp Med Biol. 2003;531:295-7. doi: 10.1007/978-1-4615-0059-9_25. Adv Exp Med Biol. 2003. PMID: 12916801 Review. No abstract available.

9

Immunohistological analysis of in situ expression of mycobacterial antigens in skin lesions of leprosy patients across the histopathological spectrum. Association of Mycobacterial lipoarabinomannan (LAM) and Mycobacterium leprae phenolic glycolipid-I (PGL-I) with leprosy reactions.

Verhagen C, Faber W, Klatser P, Buffing A, Naafs B, Das P. Verhagen C, et al. Am J Pathol. 1999 Jun;154(6):1793-804. doi: 10.1016/S0002-9440(10)65435-1. Am J Pathol. 1999. PMID: 10362804 Free PMC article.

10

Serum levels of interferon-gamma, tumour necrosis factor-alpha, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactions.

Iyer A, Hatta M, Usman R, Luiten S, Oskam L, Faber W, Geluk A, Das P. Iyer A, et al. Clin Exp Immunol. 2007 Nov;150(2):210-6. doi: 10.1111/j.1365-2249.2007.03485.x. Clin Exp Immunol. 2007. PMID: 17937676 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters